Ready to Pitstop Your Big Project or Transformation Initiative? Speedily gather breakthrough insights and ideas from all those involved in your big project or transformation initiative, without workshops, consultants or traditional reports.
https://t.co/dPGnW3maQ7
Today's real heroes aren't found in boardrooms or glossy magazines. They're at the coalface of pharmaceutical innovation – the action heroes who are making things happen.
#GrowthPitstop#Pharma
https://t.co/O7awI690gd
It is a time of uncertainty for leaders in the biotech and pharma industries. However, as this article shows, the industry's importance and resilience has never been clearer.
#Pharma#Biotech
https://t.co/5NHw6ltgqe
Early-stage biotech is tough: Founders juggle science, strategy, and fund-raising with limited people and resources. But, don’t lose hope! That is the advice of Thanos Tsagkadouras of Galino Labs and Ray Collis of Growth Pitstop.
#GrowthPitstop#Strategy
https://t.co/lr7LLVbRuS
Analysts warn of underestimating the size & sophistication of China’s pharma industry. But there is also a danger of underestimating big pharma too! In particular, the scale of its ambition and its confidence.
#GrowthPitstop
https://t.co/RYHjlZ5IdD
It is a time of uncertainty for leaders in the biotech and pharma industries. However, as this article shows, the industry's importance and resilience has never been clearer.
https://t.co/MjxvEecg8x
The threat of Chinese pharma and the prospects of a US-China trade war have been stealing the headlines. The warning is that some of big pharma's blockbuster drugs could be at risk.
https://t.co/5M0wrAZfR6
Life Sciences Product & NPD teams operate in a high-stakes environment—tight deadlines, scarce resources, complex science, and stringent regulations. With so much at play, how do the best teams maximize productivity, resilience & wellbeing?
https://t.co/hI5cUMnsxM
Most leaders of big projects and transformation initiatives regularly get asked about business impact and value. This is especially true when new technology and innovation is involved. Although essential, having the right answer isn't easy.
https://t.co/9kBPBmBDcQ
To illuminate the power of this stakeholder insight and help you engage your stakeholders, we pulled together the above analysis of senior internal stakeholders within large organizations over the past two quarters.
#Stakeholders
https://t.co/XOYQM3iYV2
Where to find the next 3%, 5% or more?
Pitstop Analytics is the fastest way to identify real opportunities to accelerate and sustain big project momentum.
https://t.co/BQBU2yMXfr
A recent study by Growth Pitstop reveals that the 'messiness' in large projects and transformations has increased by 11%. This challenges the traditional view of successful projects as smooth and structured.
https://t.co/Qnd67H2HHz
As the pressure to perform intensifies, leaders are constantly on the lookout for innovative ways to drive transformation.
Welcome to the era of the pitstop – a powerful way to turbocharge your strategy execution and propel you to the finish line.
https://t.co/e0t3ROTr1z
Thanks to all the advance readers of Super Projects in Banking & Finance. That is 100 leaders who are helping us to put the ‘super' back in conversations about change and transformation. If you would like to contribute, we would love to hear from you.
https://t.co/IUXx9VBTMO
A tribute to the incredible Eddie Jordan 💛
Drivers and Team Principals gathered on the grid, surrounded by the teams and fans, to pay their respects and celebrate the F1 legend’s life
Pharma faces pressure, but there’s reason for optimism. After years of declining R&D productivity, new tech and fresh frameworks offer hope—cutting drug development costs from billions to millions. One key factor, R&D-P, is just being recognized.
https://t.co/yrrNgqBVr7
Everyone has a story—here’s ours! We joined the Tech Business Podcast with Paul Essery to explore the challenge of quantifying performance potential. Featuring insights from John O’Gorman, Ray Collis, and the GrowthPitstop team.
https://t.co/jINWdcOUBs